title: Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.
abstract: With the intensifying global efforts to eradicate wild polioviruses, policymakers face complex decisions related to achieving eradication and managing posteradication risks. These decisions and the expanding use of inactivated poliovirus vaccine (IPV) trigger renewed interest in poliovirus immunity, particularly the role of mucosal immunity in the transmission of polioviruses. Sustained high population immunity to poliovirus transmission represents a key prerequisite to eradication, but poliovirus immunity and transmission remain poorly understood despite decades of studies. In April 2010, the U.S. Centers for Disease Control and Prevention convened an international group of experts on poliovirus immunology and virology to review the literature relevant for modeling poliovirus transmission, develop a consensus about related uncertainties, and identify research needs. This article synthesizes the quantitative assessments and research needs identified during the process. Limitations in the evidence from oral poliovirus vaccine (OPV) challenge studies and other relevant data led to differences in expert assessments, indicating the need for additional data, particularly in several priority areas for research: (1) the ability of IPV-induced immunity to prevent or reduce excretion and affect transmission, (2) the impact of waning immunity on the probability and extent of poliovirus excretion, (3) the relationship between the concentration of poliovirus excreted and infectiousness to others in different settings, and (4) the relative role of fecal-oral versus oropharyngeal transmission. This assessment of current knowledge supports the immediate conduct of additional studies to address the gaps.
authors.affiliation: Kid Risk, Inc., 10524 Moss Park Rd., Ste. 204-364, Orlando, FL 32832, USA. rdt@kidrisk.org
authors.forename: Radboud J
authors.initials: RJ
authors.lastname: Duintjer Tebbens
authors.forename: Mark A
authors.initials: MA
authors.lastname: Pallansch
authors.forename: Konstantin M
authors.initials: KM
authors.lastname: Chumakov
authors.forename: Neal A
authors.initials: NA
authors.lastname: Halsey
authors.forename: Tapani
authors.initials: T
authors.lastname: Hovi
authors.forename: Philip D
authors.initials: PD
authors.lastname: Minor
authors.forename: John F
authors.initials: JF
authors.lastname: Modlin
authors.forename: Peter A
authors.initials: PA
authors.lastname: Patriarca
authors.forename: Roland W
authors.initials: RW
authors.lastname: Sutter
authors.forename: Peter F
authors.initials: PF
authors.lastname: Wright
authors.forename: Steven G F
authors.initials: SG
authors.lastname: Wassilak
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Cochi
authors.forename: Jong-Hoon
authors.initials: JH
authors.lastname: Kim
authors.forename: Kimberly M
authors.initials: KM
authors.lastname: Thompson
mesh_terms: D006801:Humans; D011051:Poliomyelitis / Q000276:immunology* / Q000635:transmission*
references.citation: Risk Anal. 2010 Jan;30(1):107-24
references.pmid: 20002889
references.citation: Lancet. 2010 Nov 13;376(9753):1682-8
references.pmid: 20980048
references.citation: Lancet. 1994 Sep 3;344(8923):665-70
references.pmid: 7915354
references.citation: Nat Rev Microbiol. 2007 Dec;5(12):952-8
references.pmid: 17965726
references.citation: Risk Anal. 2006 Dec;26(6):1571-80
references.pmid: 17184398
references.citation: Risk Anal. 2008 Aug;28(4):1003-19
references.pmid: 18662300
references.citation: Vaccine. 2010 Jun 11;28(26):4312-27
references.pmid: 20430122
references.citation: N Engl J Med. 2007 Apr 12;356(15):1536-44
references.pmid: 17429085
references.citation: Risk Anal. 2005 Feb;25(1):109-24
references.pmid: 15787761
references.citation: Am J Epidemiol. 1996 Apr 15;143(8):816-22
references.pmid: 8610692
references.citation: Am J Public Health Nations Health. 1958 Sep;48(9):1181-92
references.pmid: 13571484
references.citation: Am J Hyg. 1962 Sep;76:173-95
references.pmid: 14469861
references.citation: Public Health Rep. 2012 Jan-Feb;127(1):23-37
references.pmid: 22298920
references.citation: Lancet. 2007 Apr 21;369(9570):1363-1371
references.pmid: 17448822
references.citation: J Infect Dis. 1993 Aug;168(2):452-4
references.pmid: 8335983
references.citation: Am J Epidemiol. 2012 May 1;175(9):936-49
references.pmid: 22459121
references.citation: Am J Epidemiol. 2005 Aug 15;162(4):358-72
references.pmid: 16014773
references.citation: Risk Anal. 2006 Dec;26(6):1541-56
references.pmid: 17184396
references.citation: Am J Epidemiol. 2010 Dec 1;172(11):1213-29
references.pmid: 20978089
references.citation: Math Biosci. 1995 Jun;127(2):149-66
references.pmid: 7795316
references.citation: Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S457-60
references.pmid: 6330841
references.citation: Risk Anal. 1992 Mar;12(1):83-93
references.pmid: 1574619
references.citation: MedGenMed. 2003 Dec 18;5(4):35
references.pmid: 14745382
references.citation: Risk Anal. 2013 Apr;33(4):544-605
references.pmid: 22804479
references.citation: Am J Epidemiol. 1969 Aug;90(2):146-56
references.pmid: 4308600
references.citation: Annu Rev Microbiol. 2005;59:587-635
references.pmid: 16153180
references.citation: Vaccine. 2009 May 5;27(20):2689-94
references.pmid: 19428880
references.citation: Vaccine. 2011 Aug 5;29(34):5793-801
references.pmid: 21641951
references.citation: Public Health Rev. 1993-1994;21(1-2):27-33
references.pmid: 8041886
references.citation: Risk Anal. 2006 Dec;26(6):1471-505
references.pmid: 17184393
references.citation: Epidemiol Rev. 1993;15(2):265-302
references.pmid: 8174658
references.citation: Medscape J Med. 2008;10(8):190
references.pmid: 18924642
references.citation: J Infect Dis. 2008 Feb 1;197(3):347-54
references.pmid: 18199031
references.citation: Am J Epidemiol. 1966 Mar;83(2):224-37
references.pmid: 5930775
references.citation: Vaccine. 1990 Oct;8(5):443-5
references.pmid: 2251870
references.citation: J Gen Virol. 1992 Dec;73 ( Pt 12):3065-77
references.pmid: 1335021
references.citation: Am J Epidemiol. 1999 Nov 15;150(10):1001-21
references.pmid: 10568615
references.citation: Med Decis Making. 2008 Mar-Apr;28(2):182-200
references.pmid: 18349438
references.citation: Science. 2005 Oct 28;310(5748):625-6
references.pmid: 16254173
references.citation: Am J Hyg. 1964 Jan;79:74-85
references.pmid: 14114357
references.citation: Risk Anal. 2013 Apr;33(4):516-43
references.pmid: 23461599
references.citation: Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S371-5
references.pmid: 6740075
references.citation: Risk Anal. 2008 Aug;28(4):855-76
references.pmid: 18627544
references.citation: Am J Public Health. 2008 Jul;98(7):1322-30
references.pmid: 18511720
references.citation: Risk Anal. 2006 Dec;26(6):1449-69
references.pmid: 17184392
references.citation: Bull World Health Organ. 1960;22:215-34
references.pmid: 14433516
references.citation: Rev Infect Dis. 1980 May-Jun;2(3):352-69
references.pmid: 6997965